BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over

Reuters
28 Feb
BRIEF-UK's MHRA Says mRESVIA RSV Vaccine Approved To Protect Patients Aged 60 And Over

Feb 28 (Reuters) - MEDICINES AND HEALTHCARE PRODUCTS REGULATORY AGENCY:

  • UK'S MHRA SAYS MRESVIA RSV VACCINE APPROVED TO PROTECT PATIENTS AGED 60 AND OVER

  • UK'S MHRA SAYS MRNA RSV VACCINE TO PROTECT PATIENTS AGED 60 AND OVER AGAINST LOWER RESPIRATORY TRACT DISEASE CAUSED BY RSV

Source text: [ID:]

Further company coverage: MRNA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10